A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the ext...
Comprehensive, easy-to-understand information about this condition
How we create this content →Connect with organizations supporting the rhabdomyosarcoma community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the rhabdomyosarcoma community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the rhabdomyosarcoma community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning rhabdomyosarcoma
Updated Feb 5, 2026
A case report highlights a rare instance of epithelioid and spindle cell rhabdomyosarcoma of the rib associated with a FUS-TFCP2 fusion. This adds to the understanding of genetic factors in this rare cancer subtype.